Connect with us

Health

Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies – News-Medical.Net

The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College…

Published

on

post featured image

The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers. They said that testing cancers for the presence of this protein may help clinicians identify patients who may be resistant to or relapse when treated with the therapy.
Epidermal growth factor receptor (EGFR) is a protein that plays a role in cell division and survival signaling and is active in skin, bladder,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending